期刊
CURRENT OPINION IN NEUROLOGY
卷 33, 期 5, 页码 641-648出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WCO.0000000000000864
关键词
amyotrophic lateral sclerosis; clinical management; genetics; staging; treatment
资金
- National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001873]
- National Center for Research Resources, National Institutes of Health [UL1RR024156]
Purpose of review The current review will provide recent updates in the clinical management of amyotrophic lateral sclerosis (ALS). Recent findings Although there is no cure for ALS, there are new treatments, growing knowledge of genetics, development of clinical staging systems, and the recent coronavirus disease 2019 pandemic that have recently impacted the clinical management of ALS. Increased understanding of genetics has helped provide insights into pathophysiology, the staging systems and clinical measures help to provide tools for monitoring disease clinically, and the recent coronavirus disease 2019 pandemic has provided opportunities to develop telemedicine and remote monitoring of disease thereby increasing accessibility to care and reducing burden of travel to centers for people living with the disease and their caregivers. ALS is a progressive neurodegenerative disease that causes degeneration of the motor neurons which leads to paralysis and respiratory failure. Despite the lack of a cure, multidisciplinary care, proactive respiratory management, nutritional care and management of symptoms as well as pharmacological interventions that can improve quality of life and survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据